[Revenues, page54 Online Games Services, page54 2. Reference is made to the first risk factor discussed on page5. Given the importance of a limited number of online games to your business, please tell us your consideration of: (i)disclosing net revenues from each online game named in this risk factor as well as net revenues in]
[For further information contact: Brad Miller, Investor Relations Director Country/City Code 8862 Tel: 2656-8016 brad.miller@gigamedia.com.tw GigaMedia Announces Second-Quarter 2012 Financial Results TAIPEI, Taiwan, August 23, 2012 GigaMedia Limited (NASDAQ: GIGM) today announced its unaudited financial results for the second quarter of 2012. In the first half of 2012 we took strong steps to turnaround our performance and build New]
[164784 Prospectus Supplement No. 1 CHINA CERAMICS CO., LTD. 8,493,642 Shares This prospectus supplement no. 1, dated August 27, 2012, supplements the prospectus dated February 14, 2011, of China Ceramics Co., Ltd., relating to the resale by selling shareholders of China Ceramics Co., Ltd. of up to 1,337,597 shares of our common stock par value $0.001 per share (“Common Stock”).]
[FORM 10 - Q/A (Mark One) [X] For the quarterly period ended: June 30, 2012 [ ] For the transition period from _________________to________________ CHINA BIOLOGIC PRODUCTS, INC. Delaware 75-2308816 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) 18th Floor, Jialong International Building Chaoyang District, Beijing 100125 (+86) 10-6598-3111 _____________________________________________________ Yes [X] No [ ] Yes [X]]
[Revenues, page54 Online Games Services, page54 2. Reference is made to the first risk factor discussed on page5. Given the importance of a limited number of online games to your business, please tell us your consideration of: (i)disclosing net revenues from each online game named in this risk factor as well as net revenues in]
[1 Announcement dated August 24, 2012 in respect of Issue of Super & Short-Term Commercial Paper.]
[FORM 10 - Q/A (Mark One) [X] For the quarterly period ended: June 30, 2012 [ ] For the transition period from _________________to________________ CHINA BIOLOGIC PRODUCTS, INC. Delaware 75-2308816 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) 18th Floor, Jialong International Building Chaoyang District, Beijing 100125 (+86) 10-6598-3111 _____________________________________________________ Yes [X] No [ ] Yes [X]]
[1 Announcement dated August 24, 2012 in respect of Issue of Super & Short-Term Commercial Paper.]
